H Uemura1, T Yasui, Y Miyatani, M Yamada, M Hiyoshi, K Arisawa, M Irahara. 1. Department of Preventive Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, 770-8503 Japan. uemura@basic.med.tokushima-u.ac.jp
Abstract
OBJECTIVE: The aim of this study was to elucidate the detail profiles of circulating osteoprotegerin (OPG) and soluble receptor activator of nuclear factor kappaB ligand (sRANKL) in post-menopausal women. METHODS: Eighty Japanese post-menopausal women were enrolled in this cross-sectional study. Circulating OPG and free fraction of sRANKL (free sRANKL), PTH, calcium and phosphorus, age, years since menopause, body mass index, bone mineral density of the vertebral bodies (LBMD) and bone turnover markers were determined in each subject. RESULTS: In rank order correlation analysis, serum OPG concentrations had a significant positive correlation with age (r=0.291, p=0.024) and a marginal significant negative correlation with LBMD (r=-0.247, p=0.062). However they did not have correlations with LBMD or other parameters after adjustment for age. Serum free sRANKL concentrations had a significant positive correlation with age (r=0.332, p=0.010) and a significant negative correlation with LBMD (r=-0.608, p<0.001). This correlation with LBMD persisted after adjustment for age. In a multiple regression analysis with a stepwise model, the main determinants of LBMD were age and serum free sRANKL (p=0.015 and p=0.006, respectively). CONCLUSIONS: We found the increase in circulating OPG and sRANKL with age and a robust negative correlation between circulating free sRANKL and LBMD after adjustment for age. The increase in circulating free sRANKL may reflect directly or indirectly the conditions coexistent with bone loss in post-menopausal women.
OBJECTIVE: The aim of this study was to elucidate the detail profiles of circulating osteoprotegerin (OPG) and soluble receptor activator of nuclear factor kappaB ligand (sRANKL) in post-menopausal women. METHODS: Eighty Japanese post-menopausal women were enrolled in this cross-sectional study. Circulating OPG and free fraction of sRANKL (free sRANKL), PTH, calcium and phosphorus, age, years since menopause, body mass index, bone mineral density of the vertebral bodies (LBMD) and bone turnover markers were determined in each subject. RESULTS: In rank order correlation analysis, serum OPG concentrations had a significant positive correlation with age (r=0.291, p=0.024) and a marginal significant negative correlation with LBMD (r=-0.247, p=0.062). However they did not have correlations with LBMD or other parameters after adjustment for age. Serum free sRANKL concentrations had a significant positive correlation with age (r=0.332, p=0.010) and a significant negative correlation with LBMD (r=-0.608, p<0.001). This correlation with LBMD persisted after adjustment for age. In a multiple regression analysis with a stepwise model, the main determinants of LBMD were age and serum free sRANKL (p=0.015 and p=0.006, respectively). CONCLUSIONS: We found the increase in circulating OPG and sRANKL with age and a robust negative correlation between circulating free sRANKL and LBMD after adjustment for age. The increase in circulating free sRANKL may reflect directly or indirectly the conditions coexistent with bone loss in post-menopausal women.
Authors: W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle Journal: Cell Date: 1997-04-18 Impact factor: 41.582
Authors: T Nakashima; Y Kobayashi; S Yamasaki; A Kawakami; K Eguchi; H Sasaki; H Sakai Journal: Biochem Biophys Res Commun Date: 2000-09-07 Impact factor: 3.575
Authors: Bo Abrahamsen; Jacob Vb Hjelmborg; Paul Kostenuik; Lis S Stilgren; Kirsten Kyvik; Stephen Adamu; Kim Brixen; Bente L Langdahl Journal: Bone Date: 2005-04 Impact factor: 4.398
Authors: Astrid Fahrleitner-Pammer; Harald Dobnig; Claudia Piswanger-Soelkner; Christine Bonelli; Hans-Peter Dimai; Georg Leb; Barbara Obermayer-Pietsch Journal: Wien Klin Wochenschr Date: 2003-05-15 Impact factor: 1.704
Authors: E G Lufkin; H W Wahner; W M O'Fallon; S F Hodgson; M A Kotowicz; A W Lane; H L Judd; R H Caplan; B L Riggs Journal: Ann Intern Med Date: 1992-07-01 Impact factor: 25.391
Authors: L Alvarez; P Peris; N Guañabens; S Vidal; I Ros; F Pons; X Filella; A Monegal; J Muñoz-Gomez; A M Ballesta Journal: Arthritis Rheum Date: 2003-03
Authors: R Okubo; L S Sanada; V A Castania; M J Q Louzada; F J A de Paula; N Maffulli; A C Shimano Journal: Osteoporos Int Date: 2017-01-26 Impact factor: 4.507
Authors: V Breuil; M Ticchioni; J Testa; C H Roux; P Ferrari; J P Breittmayer; C Albert-Sabonnadière; J Durant; F De Perreti; A Bernard; L Euller-Ziegler; G F Carle Journal: Osteoporos Int Date: 2009-10-30 Impact factor: 4.507
Authors: Andrea Z LaCroix; Rebecca D Jackson; Aaron Aragaki; Charles Kooperberg; Jane A Cauley; Zhao Chen; Meryl S Leboff; David Duggan; Jean Wactawski-Wende Journal: Bone Date: 2013-06-02 Impact factor: 4.398
Authors: Iwona Krela-Kaźmierczak; Marta Kaczmarek-Ryś; Aleksandra Szymczak; Michał Michalak; Marzena Skrzypczak-Zielińska; Natalia Drwęska-Matelska; Michalina Marcinkowska; Piotr Eder; Lilianna Łykowska-Szuber; Ewa Wysocka; Krzysztof Linke; Ryszard Słomski Journal: Calcif Tissue Int Date: 2016-09-17 Impact factor: 4.333